Life Sciences
Study findings from Wayne State University, Center for Molecular Medicine and Genetics broaden understanding of life sciences
Published in Blood Weekly, June 12th, 2008
Research findings, 'Raves and risks for erythropoietin,' are discussed in a new report. "Global use of erythropoietin (EPO) continues to increase as a proven agent for the treatment of anemia. Yet, EPO is no longer believed to have exclusive biological activity in the hematopoietic system and is now considered applicable for a variety of disorders such as diabetes, Alzheimer's disease, and cardiovascular disease," scientists writing in the journal Cytokine and Growth Factor Reviews report.
"Treatment with EPO is considered to be robust and can prevent metabolic compromise, neuronal and vascular degeneration, and inflammatory cell activation. On the converse side,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-06-12)
More Articles from Blood Weekly
- Broad Institute of Mit and Harvard
New insights into cellular reprogramming revealed by genomic analysis - International & American Association for Dental Research
NIDCR strategies for future scientific success - Cancer
Findings from F. Langer and co-authors broaden understanding of cancer - CellCyte Genetics Corporation
CellCyte Genetics Signs Collaborative Agreement With Northwestern University's Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCyte's CCG-TH30 Product Candidate - Gaucher Disease
Research on Gaucher disease reported by scientists at University of Amsterdam - Gilead Sciences, Inc.
Data from Pivotal Phase III Studies of Gilead's Letairis ambrisentan for Pulmonary Arterial Hypertension WHO Group 1 in Patients with WHO Functional Class II or III Symptoms Published in Circulation - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
